跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ANTHIM - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ANTHIM
Authorized
STANDARD
ANTHIM
Elusys Therapeutics, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
c519584c946a02dd
Company
Elusys Therapeutics, Inc.
Type
Standard
Approval Details
Approval Id
c519584c946a02dd
Drug Approval Canada Name
ANTHIM
Product Name
ANTHIM
Status
Restricted Access
Status Date
2022-09-13
Din
02502895
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Schedule D , Prescription
Ahfs
80:04.00
Atc Original
J06BC04 OBILTOXAXIMAB
Atc Name
j 06 bc 04
Aig Number
0162416001
Company Name
Elusys Therapeutics, Inc.
Company Address
310, 2001 Route 46, Parsippany, New Jersey, United States, 07054
Company Detail Path
/organization/elusys-therapeutics-inc
Company Information
Pharmaceutical Company Name
Elusys Therapeutics, Inc.
Country Name
United States
Province Name
New Jersey
City Name
新泽西州摩里斯县
Address
2001 US Highway 46 Ste 310
Website
http://www.elusys.com
Active Ingredients
OBILTOXAXIMAB
100 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
c519584c946a02dd
Type
Standard
Back to Health Canada Approvals